Skip to main content
. 2013 Jul 31;305(8):C867–C876. doi: 10.1152/ajpcell.00121.2013

Fig. 10.

Fig. 10.

A p38 MAPK activator, anisomycin, impairs forskolin-stimulated anion secretion across PVD9902 monolayers. A: representative Ussing chamber traces of vehicle or anisomycin-treated (2 μg/ml, 24 h) PVD9902 monolayers exposed to forskolin (2 μM). B: summarized results of forskolin-stimulated anion secretion from 11 paired experiments. *P < 0.05, statistical difference from vehicle.